HLA-DR Alpha 2 Mediates Negative Signalling via Binding to Tirc7 Leading to Anti-Inflammatory and Apoptotic Effects in Lymphocytes In Vitro and In Vivo | PLOS ONE
Frontiers | HLA-DR in Cytotoxic T Lymphocytes Predicts Breast Cancer Patients' Response to Neoadjuvant Chemotherapy
Artificial Antigen-Presenting Cell Topology Dictates T Cell Activation | ACS Nano
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia | Nature Communications
JoF | Free Full-Text | Longitudinal Changes in CD4+, CD8+ T Cell Phenotype and Activation Marker Expression Following Antiretroviral Therapy Initiation among Patients with Cryptococcal Meningitis
T cell activation | T cell differentiation | Miltenyi | USA
Expression of the T cell activation markers HLA-DR and CD38 on... | Download Scientific Diagram
Cortisol Patterns Are Associated with T Cell Activation in HIV | PLOS ONE
Frontiers | HLA-DR in Cytotoxic T Lymphocytes Predicts Breast Cancer Patients' Response to Neoadjuvant Chemotherapy
Chronically Activated T-cells Retain Their Inflammatory Properties in Common Variable Immunodeficiency | SpringerLink
Frontiers | Role of Different Subpopulations of CD8+ T Cells during HIV Exposure and Infection
Expression of activation (CD38 and HLA-DR) and senescence (CD57 and... | Download Scientific Diagram
T-Cell Activation | Sartorius
Early (CD69) and late (HLA-DR) activation marker expression by T cells... | Download Scientific Diagram
T-cell activation marker expression is altered in the presence of... | Download Scientific Diagram
Cancers | Free Full-Text | Expression of HLA-DR in Cytotoxic T Lymphocytes: A Validated Predictive Biomarker and a Potential Therapeutic Strategy in Breast Cancer
Potential Role for HIV-Specific CD38−/HLA-DR+ CD8+ T Cells in Viral Suppression and Cytotoxicity in HIV Controllers | PLOS ONE
iQue® Human T Cell Activation Kit
Activation markers of peripheral blood mononuclear cells in late pregnancy and after delivery: a pilot study | Annals of the Rheumatic Diseases
Solitomab, an EpCAM/CD3 bispecific antibody construct (BiTE®), is highly active against primary uterine and ovarian carcinosarcoma cell lines in vitro | Journal of Experimental & Clinical Cancer Research | Full Text
Memory B Cells Activate Brain-Homing, Autoreactive CD4+ T Cells in Multiple Sclerosis - ScienceDirect
A) representative flow cytometry plots of CD38 and HLA-DR expression on... | Download Scientific Diagram
IJMS | Free Full-Text | Induction of a Regulatory Phenotype in CD3+ CD4+ HLA-DR+ T Cells after Allogeneic Mixed Lymphocyte Culture; Indications of Both Contact-Dependent and -Independent Activation
A Guide to Regulatory T Cell Markers | Biocompare: The Buyer's Guide for Life Scientists
Targeting HLA-DR loss in hematologic malignancies with an inhibitory chimeric antigen receptor: Molecular Therapy
